Authors
Qi Shao
Published in
Journal of global health. Volume 16. Pages 03036. Nov 13, 2026. Epub Nov 13, 2026.
Abstract
The World Health Organization (WHO) Pandemic Agreement depends on a workable Pathogen Access and Benefit-Sharing (PABS) annex that can reconcile rapid pathogen sharing with equitable access to pandemic-related benefits. This viewpoint presents a testable downstream accountability proposal rather than a description of agreed PABS rules. Article 12 already establishes the PABS system, requires the annex to address traceability, provides for legally binding contracts with participating manufacturers, and sets a target for WHO access to 20% of real-time production during a pandemic emergency. The proposal developed here adds an operational downstream trigger, persistent provenance identifiers, pass-through contractual duties, transparent compliance review, and pooled allocation. Routine public-health and non-commercial scientific access would remain rapid and low-friction, and obligations would arise when documented PABS use enters defined product-oriented, intellectual-property, regulatory, licensing, manufacturing, or commercial activity. Persistent identifiers would document provenance, not legal causation, while pooled benefit sharing would avoid sequence-by-sequence valuation. The model also acknowledges unresolved questions of legal authority, national access and benefit-sharing law, allocation governance, non-participating manufacturers, and political acceptability that require negotiation and prospective testing.
PMID:
43023586
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0